Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture, and sale of pharmaceutical products. The company employs 1,036 full-time employees The company went IPO on 2002-07-15. The firm operates its business through two segments. The Imported Products segment is engaged in the sale of imported products. Its imported products include Keyan injection, Fipril oral solution and others. The Proprietary Products segment is engaged in the manufacture and sale of self-developed products. Its R&D products include Resilicon Tablets, ADASUVE Inhalation Powder and others. The firm's medicines cover the fields of cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology. The firm mainly operates its business in mainland China, Hong Kong and Taiwan.
Lee's Pharmaceutical Holdings Ltd Información sobre dividendos
Lee's Pharmaceutical Holdings Ltd tiene un dividendo anual de 0.01 por acción, con un rendimiento del 0.00%. El dividendo se paga semestralmente y la última fecha ex-dividendo fue Sep 12, 2025.
Rendimiento de dividendos
Dividendo anual
Fecha de ex-dividendos
0.00%
$0.01
Sep 12, 2025
Frecuencia de pago
Relación de pago
Semestralmente
0.00%
Historial de dividendos
Fecha de ex-dividendos
Monto en efectivo
Fecha de Registro
Fecha de Pago
Sep 12, 2025
$0.022
Sep 15, 2025
Oct 3, 2025
May 28, 2025
$0.025
May 29, 2025
Jun 16, 2025
Sep 12, 2024
$0.02
Sep 13, 2024
Oct 3, 2024
May 28, 2024
$0.01
May 29, 2024
Jun 17, 2024
Sep 12, 2023
$0.008
Sep 13, 2023
Oct 4, 2023
May 25, 2023
$0.01
May 29, 2023
Jun 15, 2023
Gráficos de dividendos
LPCUF Dividendos
LPCUF Crecimiento de Dividendos (YoY)
Follow-Up Questions
¿Cuál es el dividendo actual pagado por Lee's Pharmaceutical Holdings Ltd y su dividendo anual?
¿Cuál es el ratio de pago de dividendos de Lee's Pharmaceutical Holdings Ltd?